NewGenIvf Group Shares to Reverse Split on Monday, October 12th (NASDAQ:NIVF)

Posted by Francis Steltz on Oct 8th, 2026

NewGenIvf Group Limited (NASDAQ:NIVF – Free Report)’s stock is set to reverse split on Monday, October 12th. The 1-4 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, October 11th.

NewGenIvf Group Stock Down 23.5%

Shares of NewGenIvf Group stock traded down $0.02 during trading hours on Thursday, reaching $0.08. 18,737,952 shares of the company were exchanged, compared to its average volume of 75,441,272. NewGenIvf Group has a 1 year low of $0.06 and a 1 year high of $1,539.00. The stock’s fifty day moving average is $1.12 and its 200 day moving average is $6.93.

NewGenIvf Group (NASDAQ:NIVF – Get Free Report) last announced its quarterly earnings data on Wednesday, October 7th. The company reported ($13.32) earnings per share (EPS) for the quarter. The firm had revenue of $0.96 million during the quarter. As a group, equities analysts expect that NewGenIvf Group will post 42.67 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

NIVF has been the subject of several recent research reports. Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a research note on Friday, July 24th. Wall Street Zen upgraded shares of NewGenIvf Group to a “hold” rating in a research note on Saturday, July 4th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, NewGenIvf Group has an average rating of “Sell”.

View Our Latest Research Report on NIVF

Insider Activity

In other news, Director Kong Yiu Cheung acquired 2,500,000 shares of the firm’s stock in a transaction dated Monday, July 27th. The stock was acquired at an average cost of $1.00 per share, with a total value of $2,500,000.00. Following the transaction, the director owned 3,722,223 shares in the company, valued at approximately $3,722,223. This trade represents a 204.55% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 31.80% of the company’s stock.

NewGenIvf Group Company Profile

(Get Free Report)

NewGenIvf Group Limited is a fertility-services company that provides assisted reproductive and related medical services. Through its NewGen IVF network, the company serves individuals and couples seeking fertility evaluation, in vitro fertilization (IVF), and other treatments designed to support conception.

Its services include fertility consultations and diagnostic testing, ovarian stimulation, egg retrieval, embryo transfer, intracytoplasmic sperm injection (ICSI), embryo and reproductive-cell freezing, and preimplantation genetic testing.